Symbols / MSD Stock $7.37 -0.41% Morgan Stanley Emerging Markets Debt Fund, Inc.
MSD (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Morgan Stanley Emerging Markets Debt Fund, Inc. is a closed ended fixed income fund launched and managed by Morgan Stanley Investment Management Inc. The fund invests in fixed income markets of emerging market countries across the globe. It primarily invests in debt securities of government and government-related issuers, of entities organized to restructure outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries. The fund benchmarks the performance of its portfolio against the JP Morgan Emerging Markets Bond Global Index. Morgan Stanley Emerging Markets Debt Fund, Inc. was formed on May 6, 1993 and is domiciled in the United States.
Ratings
Current target
$7.37
Low
—
High
—
Mean
—
News
RSS: Latest MSD news- (MSD) Volatility Zones as Tactical Triggers - Stock Traders Daily Wed, 22 Apr 2026 13
- MSD shares drop 5% amid plans for $3bn cost cutting strategy - Pharmaceutical Technology ue, 29 Jul 2025 07
- BDT & MSD's Alliance Laundry targets $4.3 billion valuation in US IPO - Reuters Mon, 29 Sep 2025 07
- Morgan (MSD) Stock: Should You Take a Position (Steady Climb) 2026-04-18 - Expert Breakout Alerts - Cổng thông tin điện tử tỉnh Tây Ninh Sun, 19 Apr 2026 01
- Morgan (MSD) Stock: Why Consistent Earnings (-0.13%) 2026-04-20 - Professional Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai Mon, 20 Apr 2026 15
- Citi Trends Posts HSD Comps Over MSD Comps, But The Stock Is Years Ahead Fundamentals - Seeking Alpha ue, 09 Dec 2025 08
- BDT & MSD's Alliance Laundry targets $4.3 billion valuation in US IPO - Yahoo! Finance Canada Mon, 29 Sep 2025 07
- Alliance Laundry, Backer BDT & MSD Raise $826 Million in IPO - Bloomberg.com Wed, 08 Oct 2025 07
- Price-Driven Insight from (MSD) for Rule-Based Strategy - Stock Traders Daily Sat, 11 Apr 2026 11
- Alteogen Stock Drops Amid German Sales Ban Ruling - Businesskorea Fri, 05 Dec 2025 08
- MSD: Not As Well-Positioned As Its Peers And Likely To Continue Underperforming - Seeking Alpha Mon, 15 Sep 2025 07
- SK Bioscience Co Ltd stock surges on $30M CEPI funding for MSD Ebola vaccine partnership - AD HOC NEWS Wed, 25 Mar 2026 07
- MSD Stock Price, News & Analysis - Stock Titan Fri, 25 Apr 2025 01
- BDT & MSD’s Alliance Laundry Files for IPO With Plan to Cut Debt - Bloomberg.com Fri, 12 Sep 2025 07
- Hanmi Pharma Stock Falls 10% After MSD Omits Drug From Presentation - Seoul Economic Daily ue, 13 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
21.68
+28.52%
|
16.87
-3.59%
|
17.50
+146.99%
|
-37.25
|
| Operating Revenue |
|
21.68
+28.52%
|
16.87
-3.59%
|
17.50
+146.99%
|
-37.25
|
| Operating Expense |
|
0.55
+9.49%
|
0.51
-0.98%
|
0.51
+49.85%
|
0.34
|
| Selling General And Administration |
|
0.61
+8.67%
|
0.56
-0.70%
|
0.57
+40.84%
|
0.40
|
| General And Administrative Expense |
|
0.61
+8.67%
|
0.56
-0.70%
|
0.57
+40.84%
|
0.40
|
| Other Operating Expenses |
|
-0.06
-1.69%
|
-0.06
-1.72%
|
-0.06
+7.94%
|
-0.06
|
| Net Income |
|
21.13
+29.11%
|
16.37
-3.67%
|
16.99
+145.20%
|
-37.59
|
| Pretax Income |
|
21.13
+29.11%
|
16.37
-3.67%
|
16.99
+145.20%
|
-37.59
|
| Net Interest Income |
|
12.96
-38.01%
|
20.92
+42.92%
|
14.63
+15.64%
|
12.66
|
| Interest Income |
|
12.96
-38.01%
|
20.92
+42.92%
|
14.63
+15.64%
|
12.66
|
| Gain On Sale Of Security |
|
-4.84
-402.25%
|
1.60
+105.84%
|
-27.42
-18.93%
|
-23.05
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
21.13
+29.11%
|
16.37
-3.67%
|
16.99
+145.20%
|
-37.59
|
| Net Income From Continuing Operation Net Minority Interest |
|
21.13
+29.11%
|
16.37
-3.67%
|
16.99
+145.20%
|
-37.59
|
| Net Income From Continuing And Discontinued Operation |
|
21.13
+29.11%
|
16.37
-3.67%
|
16.99
+145.20%
|
-37.59
|
| Net Income Continuous Operations |
|
21.13
+29.11%
|
16.37
-3.67%
|
16.99
+145.20%
|
-37.59
|
| Normalized Income |
|
21.13
+29.11%
|
16.37
-3.67%
|
16.99
+145.20%
|
-37.59
|
| Net Income Common Stockholders |
|
21.13
+29.11%
|
16.37
-3.67%
|
16.99
+145.20%
|
-37.59
|
| Diluted EPS |
|
—
|
0.81
-4.71%
|
0.85
+145.95%
|
-1.85
|
| Basic EPS |
|
—
|
0.81
-4.71%
|
0.85
+145.95%
|
-1.85
|
| Basic Average Shares |
|
—
|
20.21
+1.08%
|
19.99
-1.62%
|
20.32
|
| Diluted Average Shares |
|
—
|
20.21
+1.08%
|
19.99
-1.62%
|
20.32
|
| Diluted NI Availto Com Stockholders |
|
21.13
+29.11%
|
16.37
-3.67%
|
16.99
+145.20%
|
-37.59
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
163.50
+3.13%
|
158.53
-0.78%
|
159.78
+0.67%
|
158.71
|
| Cash And Cash Equivalents |
|
0.12
-53.39%
|
0.25
|
0.00
-100.00%
|
0.31
|
| Cash Financial |
|
0.12
-53.39%
|
0.25
|
0.00
-100.00%
|
0.31
|
| Receivables |
|
5.12
+13.04%
|
4.53
-13.11%
|
5.21
+5.88%
|
4.92
|
| Investments And Advances |
|
158.25
+2.93%
|
153.74
-0.52%
|
154.54
+0.71%
|
153.45
|
| Total Liabilities Net Minority Interest |
|
4.33
-27.50%
|
5.97
+15.35%
|
5.18
+15.26%
|
4.49
|
| Payables |
|
3.53
-36.33%
|
5.54
+31.62%
|
4.21
+59.47%
|
2.64
|
| Accounts Payable |
|
3.31
-38.17%
|
5.35
+32.57%
|
4.04
+65.09%
|
2.45
|
| Other Payable |
|
0.22
+15.96%
|
0.19
+9.30%
|
0.17
-11.34%
|
0.19
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
—
|
0.05
|
—
|
| Stockholders Equity |
|
159.16
+4.33%
|
152.56
-1.32%
|
154.60
+0.25%
|
154.21
|
| Common Stock Equity |
|
159.16
+4.33%
|
152.56
-1.32%
|
154.60
+0.25%
|
154.21
|
| Capital Stock |
|
0.20
+0.00%
|
0.20
+0.00%
|
0.20
-0.98%
|
0.20
|
| Common Stock |
|
0.20
+0.00%
|
0.20
+0.00%
|
0.20
-0.98%
|
0.20
|
| Share Issued |
|
20.23
+0.16%
|
20.20
+0.04%
|
20.19
-0.96%
|
20.39
|
| Ordinary Shares Number |
|
20.23
+0.16%
|
20.20
+0.04%
|
20.19
-0.96%
|
20.39
|
| Additional Paid In Capital |
|
231.54
-0.03%
|
231.62
+0.03%
|
231.55
-0.72%
|
233.23
|
| Retained Earnings |
|
-72.58
+8.43%
|
-79.27
-2.73%
|
-77.16
+2.60%
|
-79.22
|
| Total Equity Gross Minority Interest |
|
159.16
+4.33%
|
152.56
-1.32%
|
154.60
+0.25%
|
154.21
|
| Total Capitalization |
|
—
|
—
|
154.65
|
—
|
| Invested Capital |
|
—
|
—
|
154.65
|
—
|
| Total Debt |
|
—
|
—
|
0.05
|
—
|
| Net Debt |
|
—
|
—
|
0.05
|
—
|
| Net Tangible Assets |
|
159.16
+4.33%
|
152.56
-1.32%
|
154.60
+0.25%
|
154.21
|
| Tangible Book Value |
|
159.16
+4.33%
|
152.56
-1.32%
|
154.60
+0.25%
|
154.21
|
| Available For Sale Securities |
|
5.61
+25.13%
|
4.49
-39.54%
|
7.42
-52.42%
|
15.59
|
| Cash Cash Equivalents And Federal Funds Sold |
|
0.12
-53.39%
|
0.25
|
0.00
-100.00%
|
0.31
|
| Derivative Product Liabilities |
|
0.16
+485.71%
|
0.03
-93.81%
|
0.45
-6.22%
|
0.48
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
152.60
+2.43%
|
148.97
+1.28%
|
147.09
+6.75%
|
137.78
|
| Investmentin Financial Assets |
|
158.25
+2.93%
|
153.74
-0.52%
|
154.54
+0.71%
|
153.45
|
No cash flow data available.
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42004-08-05 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|